scispace - formally typeset
G

Gad Getz

Researcher at Broad Institute

Publications -  627
Citations -  309042

Gad Getz is an academic researcher from Broad Institute. The author has contributed to research in topics: Cancer & Biology. The author has an hindex of 189, co-authored 520 publications receiving 247560 citations. Previous affiliations of Gad Getz include University of Colorado Denver & University of California, San Diego.

Papers
More filters
Journal ArticleDOI

Regulation of Transient Site-specific Copy Gain by MicroRNA

TL;DR: It is demonstrated that KDM4A is regulated by hSA-mir-23a-3p, hsa-Mir-23b-3 p, and hsa -mir-137, which are identified as regulators of TSSG and copy gains of a drug resistance gene.
Journal ArticleDOI

Diverse mutational landscapes in human lymphocytes

TL;DR: In this paper , the authors sequenced whole genomes from 717 normal naive and memory B and T cells and haematopoietic stem cells and found that all lymphocyte subsets carried more point mutations and structural variants than stem cells, with higher burdens in memory cells than in naive cells and with T cells accumulating mutations at a higher rate throughout life.
Journal ArticleDOI

Quantification of somatic mutation flow across individual cell division events by lineage sequencing.

TL;DR: Lineage sequencing is presented, a new genome sequencing approach that enables somatic event reconstruction by providing quality somatic mutation call sets with resolution as high as the single-cell level in subject lineages and shows that mutations arrive with nonuniform probability across sublineages and that DNA lesion dynamics may cause strong correlations between certain mutations.
Journal ArticleDOI

Accurate estimation of homologue-specific DNA concentration-ratios in cancer samples allows long-range haplotyping

TL;DR: The ability to directly determine haplotypes from cancer samples represents an opportunity to expand reference panels of phased chromosomes, which may have general interest in various population genetic applications and may be exploited to interrogate the relationship between germline risk and cancer phenotype with greater sensitivity than is possible using unphased genotype.